| |

A New Mesothelioma Risk Score for Patients with Pre-Treated Malignant Pleural Mesothelioma

A New Mesothelioma Risk Score for Patients with Pre-Treated Malignant Pleural MesotheliomaThere has been some encouraging news for patients with pre-treated malignant pleural mesothelioma. A new mesothelioma risk score has been developed for pre-treated mesothelioma patients.

The new score is predictive of patient outcomes and it informs a better treatment strategy for second-line treatment. Results come from an international team of oncologists from Italy, the United Kingdom, Switzerland, Greece, and Spain.

The Pre-Treated Mesothelioma Patient

The young (65 years or younger) mesothelioma patients who have received treatment once before are often called “pre-treated.” Clinicians often have more personalized data available for these patients. But there are many different factors that affect the clinician’s treatment strategy.

The best treatment for pre-treated mesothelioma patients is still up for debate. Many clinicians use a chemotherapy option. But, immunotherapy options have also proven effective second-line treatments.

Clinicians need a better way to consider all the options. This helps them to select the best treatment strategy for pre-treated mesothelioma patients.

A Mesothelioma Risk Score

The goal of Dr. Stahel’s study was to identify clinical and laboratory factors that could be used for prognosis or prediction. They looked at patients with malignant pleural mesothelioma undergoing second-line treatment.

A similar group tried to solve this problem earlier. The European Organization for Research and Treatment of Cancer (EORTC) score system was validated in the first-line treatment of mesothelioma. It provides the best recurrence and progression prediction for those newly diagnosed.

Dr. Stahel’s team developed the new Mesothelioma Risk Score for the second-line treatment. This score is for patients pre-treated either with chemotherapy or immunotherapy. For this group, there are extra concerns to avoid overtreatment and optimize resources.

The new Mesothelioma Risk Score was recently published in Lung Cancer. It achieves better predictive results than the EORTC score alone for pre-treated mesothelioma patients.

The international team tested the new risk score on 144 patients participating in the ETOP 9–15 PROMISE-meso trial. The score works by looking at certain clinical factors in a patient’s history and the results of a blood test.

An international team of oncologists have proven a new Mesothelioma Risk Score for pre-treated mesothelioma patients. This new risk score is proven better than the existing EORTC score alone for cancer patients. This new score helps oncologists find the best treatment for pre-treated mesothelioma patients.

Source:

Banna, Giuseppe Luigi, Alfredo Addeo, Panagiota Zygoura, Zoi Tsourti, Sanjay Popat, Alessandra Curioni-Fontecedro, Ernest Nadal et al. “A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9–15 PROMISE-meso phase III trial.” Lung Cancer (2022). https://doi.org/10.1016/j.lungcan.2022.05.018

 

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…